Symbols / XLO Stock $8.32 +5.05% Xilio Therapeutics, Inc.
XLO (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
No company description available for this symbol.
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest XLO news- Xilio Therapeutics (XLO) grants director 10,000 stock options at $8.40 - Stock Titan hu, 16 Apr 2026 07
- Net current asset value per share of Xilio Therapeutics, Inc. – NASDAQ:XLO - TradingView Fri, 01 May 2026 01
- Xilio Therapeutics (XLO) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance Wed, 01 Apr 2026 07
- Cancer drug candidate showed tumor killing without cytokine syndrome - Stock Titan Fri, 17 Apr 2026 07
- Xilio Therapeutics (XLO) price target decreased by 28.57% to 20.40 - MSN hu, 30 Apr 2026 05
- Xilio Therapeutics Announces Pricing of $40 Million Underwritten Offering of Pre-Funded Warrants - Quiver Quantitative hu, 12 Feb 2026 08
- Xilio Therapeutics Shareholders Approve Flexible Reverse Stock Split - The Globe and Mail Wed, 25 Feb 2026 08
- Stock plan change and virtual 2026 annual meeting at Xilio (XLO) - Stock Titan ue, 28 Apr 2026 21
- Xilio Therapeutics announces 1-for-14 reverse stock split - MSN Fri, 24 Apr 2026 06
- Cancer biotech Xilio enacts 1-for-14 reverse split to regain Nasdaq compliance - Stock Titan hu, 12 Mar 2026 07
- Cancer drug developer targets 2026 trial start with cash into 2027 - Stock Titan Mon, 23 Mar 2026 07
- XLO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan Wed, 22 Apr 2026 07
- Cancer drug developer Xilio raises $40M in warrant deal - Stock Titan Wed, 11 Feb 2026 08
- Xilio brings in a 30-year biotech veteran as board member - Stock Titan hu, 16 Apr 2026 07
- Xilio Therapeutics gives 2 new hires stock options at $8.48 a share - Stock Titan Fri, 03 Apr 2026 07
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
43.77
+589.88%
|
6.34
|
0.00
|
0.00
|
| Operating Revenue |
|
43.77
+589.88%
|
6.34
|
0.00
|
0.00
|
| Operating Expense |
|
85.75
+29.94%
|
65.99
-16.61%
|
79.13
-11.24%
|
89.15
|
| Research And Development |
|
56.04
+35.98%
|
41.21
-20.95%
|
52.14
-11.93%
|
59.20
|
| Selling General And Administration |
|
29.71
+19.90%
|
24.78
-8.22%
|
27.00
-9.85%
|
29.95
|
| General And Administrative Expense |
|
29.71
+19.90%
|
24.78
-8.22%
|
27.00
-9.85%
|
29.95
|
| Salaries And Wages |
|
16.32
+11.44%
|
14.65
-7.46%
|
15.83
-5.23%
|
16.70
|
| Other Gand A |
|
13.39
+32.14%
|
10.13
-9.29%
|
11.17
-15.68%
|
13.25
|
| Total Expenses |
|
85.75
+29.94%
|
65.99
-16.61%
|
79.13
-11.24%
|
89.15
|
| Operating Income |
|
-41.98
+29.61%
|
-59.65
+24.63%
|
-79.13
+11.24%
|
-89.15
|
| Total Operating Income As Reported |
|
-41.98
+30.70%
|
-60.58
+23.44%
|
-79.13
+11.24%
|
-89.15
|
| EBITDA |
|
-40.44
+30.28%
|
-58.00
+24.90%
|
-77.23
+11.53%
|
-87.30
|
| Normalized EBITDA |
|
-46.29
+18.89%
|
-57.06
+26.11%
|
-77.23
+11.53%
|
-87.30
|
| Reconciled Depreciation |
|
1.54
-6.27%
|
1.64
-13.47%
|
1.90
+2.87%
|
1.85
|
| EBIT |
|
-41.98
+29.61%
|
-59.65
+24.63%
|
-79.13
+11.24%
|
-89.15
|
| Total Unusual Items |
|
5.84
+723.80%
|
-0.94
|
0.00
|
—
|
| Total Unusual Items Excluding Goodwill |
|
5.84
+723.80%
|
-0.94
|
0.00
|
—
|
| Special Income Charges |
|
0.00
+100.00%
|
-0.94
|
0.00
|
—
|
| Restructuring And Mergern Acquisition |
|
0.00
-100.00%
|
0.94
|
0.00
|
—
|
| Net Income |
|
-35.04
+39.84%
|
-58.24
+23.77%
|
-76.40
+13.40%
|
-88.22
|
| Pretax Income |
|
-35.04
+39.84%
|
-58.24
+23.77%
|
-76.40
+13.40%
|
-88.22
|
| Other Income Expense |
|
6.95
+394.73%
|
1.40
-48.55%
|
2.73
+194.39%
|
0.93
|
| Other Non Operating Income Expenses |
|
1.10
-52.97%
|
2.34
-14.22%
|
2.73
+194.39%
|
0.93
|
| Gain On Sale Of Security |
|
5.84
|
—
|
—
|
—
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-35.04
+39.84%
|
-58.24
+23.77%
|
-76.40
+13.40%
|
-88.22
|
| Net Income From Continuing Operation Net Minority Interest |
|
-35.04
+39.84%
|
-58.24
+23.77%
|
-76.40
+13.40%
|
-88.22
|
| Net Income From Continuing And Discontinued Operation |
|
-35.04
+39.84%
|
-58.24
+23.77%
|
-76.40
+13.40%
|
-88.22
|
| Net Income Continuous Operations |
|
-35.04
+39.84%
|
-58.24
+23.77%
|
-76.40
+13.40%
|
-88.22
|
| Normalized Income |
|
-40.88
+28.66%
|
-57.30
+25.00%
|
-76.40
+13.40%
|
-88.22
|
| Net Income Common Stockholders |
|
-35.04
+39.84%
|
-58.24
+23.77%
|
-76.40
+13.40%
|
-88.22
|
| Diluted EPS |
|
-4.19
+72.54%
|
-15.26
+60.79%
|
-38.92
+13.66%
|
-45.08
|
| Basic EPS |
|
-4.19
+72.54%
|
-15.26
+60.79%
|
-38.92
+13.66%
|
-45.08
|
| Basic Average Shares |
|
8.36
+118.70%
|
3.82
+94.61%
|
1.96
+0.38%
|
1.96
|
| Diluted Average Shares |
|
8.36
+118.70%
|
3.82
+94.61%
|
1.96
+0.38%
|
1.96
|
| Diluted NI Availto Com Stockholders |
|
-35.04
+39.84%
|
-58.24
+23.77%
|
-76.40
+13.40%
|
-88.22
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
154.69
+117.64%
|
71.08
+16.66%
|
60.93
-56.22%
|
139.16
|
| Current Assets |
|
145.03
+140.77%
|
60.23
+25.16%
|
48.13
-61.34%
|
124.50
|
| Cash Cash Equivalents And Short Term Investments |
|
137.53
+148.74%
|
55.29
+23.68%
|
44.70
-62.87%
|
120.39
|
| Cash And Cash Equivalents |
|
137.53
+148.74%
|
55.29
+23.68%
|
44.70
-62.87%
|
120.39
|
| Receivables |
|
5.00
|
0.00
|
—
|
—
|
| Other Receivables |
|
5.00
|
—
|
—
|
—
|
| Prepaid Assets |
|
—
|
—
|
—
|
4.11
|
| Other Current Assets |
|
2.50
-49.50%
|
4.94
+44.41%
|
3.42
-16.74%
|
4.11
|
| Total Non Current Assets |
|
9.66
-10.91%
|
10.84
-15.30%
|
12.80
-12.75%
|
14.67
|
| Net PPE |
|
7.85
-13.33%
|
9.06
-18.14%
|
11.07
-13.81%
|
12.84
|
| Gross PPE |
|
16.60
+0.72%
|
16.49
-2.61%
|
16.93
-1.91%
|
17.26
|
| Accumulated Depreciation |
|
-8.75
-17.85%
|
-7.43
-26.72%
|
-5.86
-32.66%
|
-4.42
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Buildings And Improvements |
|
—
|
4.59
-10.50%
|
5.12
|
—
|
| Machinery Furniture Equipment |
|
0.68
-21.18%
|
0.86
+0.00%
|
0.86
+0.00%
|
0.86
|
| Construction In Progress |
|
0.46
|
0.00
|
0.00
-100.00%
|
0.10
|
| Other Properties |
|
10.34
-1.51%
|
10.50
-4.04%
|
10.94
-2.08%
|
11.17
|
| Leases |
|
5.12
+0.00%
|
5.12
+0.00%
|
5.12
+0.00%
|
5.12
|
| Other Non Current Assets |
|
1.81
+1.40%
|
1.78
+2.89%
|
1.73
-5.30%
|
1.83
|
| Total Liabilities Net Minority Interest |
|
119.41
+123.30%
|
53.48
+121.91%
|
24.10
-28.10%
|
33.52
|
| Current Liabilities |
|
56.27
+106.42%
|
27.26
+70.84%
|
15.96
-24.44%
|
21.12
|
| Payables And Accrued Expenses |
|
9.17
+9.91%
|
8.35
+21.73%
|
6.86
-14.70%
|
8.04
|
| Payables |
|
3.17
+23.08%
|
2.57
+145.14%
|
1.05
-66.40%
|
3.12
|
| Accounts Payable |
|
3.17
+23.08%
|
2.57
+145.14%
|
1.05
-66.40%
|
3.12
|
| Current Accrued Expenses |
|
6.01
+4.04%
|
5.77
-0.59%
|
5.81
+18.17%
|
4.91
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
5.73
+36.24%
|
4.21
-10.28%
|
4.69
-13.36%
|
5.41
|
| Current Debt And Capital Lease Obligation |
|
1.34
+13.05%
|
1.19
-72.76%
|
4.36
-42.49%
|
7.58
|
| Current Debt |
|
—
|
—
|
3.31
-50.28%
|
6.67
|
| Other Current Borrowings |
|
—
|
—
|
3.31
-50.28%
|
6.67
|
| Current Capital Lease Obligation |
|
1.34
+13.05%
|
1.19
+13.47%
|
1.05
+14.05%
|
0.92
|
| Current Deferred Liabilities |
|
40.02
+196.07%
|
13.52
|
0.00
|
—
|
| Current Deferred Revenue |
|
40.02
+196.07%
|
13.52
|
0.00
|
—
|
| Other Current Liabilities |
|
—
|
—
|
0.05
-41.46%
|
0.08
|
| Total Non Current Liabilities Net Minority Interest |
|
63.14
+140.84%
|
26.22
+221.98%
|
8.14
-34.33%
|
12.40
|
| Long Term Debt And Capital Lease Obligation |
|
5.61
-19.31%
|
6.95
-14.59%
|
8.14
-34.09%
|
12.35
|
| Long Term Debt |
|
—
|
—
|
—
|
3.17
|
| Long Term Capital Lease Obligation |
|
5.61
-19.31%
|
6.95
-14.59%
|
8.14
-11.39%
|
9.19
|
| Non Current Deferred Liabilities |
|
20.64
+7.13%
|
19.26
|
0.00
|
—
|
| Non Current Deferred Revenue |
|
20.64
+7.13%
|
19.26
|
0.00
|
—
|
| Other Non Current Liabilities |
|
7.33
|
—
|
—
|
0.04
|
| Stockholders Equity |
|
35.27
+100.44%
|
17.60
-52.21%
|
36.83
-65.14%
|
105.65
|
| Common Stock Equity |
|
35.27
+100.44%
|
17.60
-52.21%
|
36.83
-65.14%
|
105.65
|
| Capital Stock |
|
0.00
|
0.00
-100.00%
|
0.00
+0.00%
|
0.00
|
| Common Stock |
|
0.00
|
0.00
-100.00%
|
0.00
+0.00%
|
0.00
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
4.53
+38.62%
|
3.27
-88.16%
|
27.61
+0.66%
|
27.43
|
| Ordinary Shares Number |
|
4.53
+38.62%
|
3.27
-88.16%
|
27.61
+0.66%
|
27.43
|
| Additional Paid In Capital |
|
454.06
+13.13%
|
401.35
+10.77%
|
362.34
+2.14%
|
354.75
|
| Retained Earnings |
|
-418.79
-9.13%
|
-383.75
-17.89%
|
-325.51
-30.67%
|
-249.11
|
| Total Equity Gross Minority Interest |
|
35.27
+100.44%
|
17.60
-52.21%
|
36.83
-65.14%
|
105.65
|
| Total Capitalization |
|
35.27
+100.44%
|
17.60
-52.21%
|
36.83
-66.16%
|
108.81
|
| Working Capital |
|
88.75
+169.17%
|
32.97
+2.50%
|
32.17
-68.88%
|
103.38
|
| Invested Capital |
|
35.27
+100.44%
|
17.60
-56.16%
|
40.14
-65.24%
|
115.48
|
| Total Debt |
|
6.95
-14.59%
|
8.14
-34.88%
|
12.50
-37.29%
|
19.94
|
| Capital Lease Obligations |
|
6.95
-14.59%
|
8.14
-11.39%
|
9.19
-9.08%
|
10.11
|
| Net Tangible Assets |
|
35.27
+100.44%
|
17.60
-52.21%
|
36.83
-65.14%
|
105.65
|
| Tangible Book Value |
|
35.27
+100.44%
|
17.60
-52.21%
|
36.83
-65.14%
|
105.65
|
| Derivative Product Liabilities |
|
29.56
|
0.00
|
—
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-4.99
+72.84%
|
-18.38
+73.22%
|
-68.62
+9.38%
|
-75.72
|
| Cash Flow From Continuing Operating Activities |
|
-4.99
+72.84%
|
-18.38
+73.22%
|
-68.62
+9.38%
|
-75.72
|
| Net Income From Continuing Operations |
|
-35.04
+39.84%
|
-58.24
+23.77%
|
-76.40
+13.40%
|
-88.22
|
| Depreciation Amortization Depletion |
|
1.54
-6.27%
|
1.64
-13.47%
|
1.90
+2.87%
|
1.85
|
| Depreciation And Amortization |
|
1.54
-6.27%
|
1.64
-13.47%
|
1.90
+2.87%
|
1.85
|
| Other Non Cash Items |
|
—
|
—
|
0.16
-29.60%
|
0.22
|
| Stock Based Compensation |
|
6.94
+7.85%
|
6.43
-12.84%
|
7.38
-12.37%
|
8.42
|
| Operating Gains Losses |
|
-3.56
-118800.00%
|
0.00
+0.00%
|
0.00
+200.00%
|
0.00
|
| Gain Loss On Investment Securities |
|
-3.56
|
—
|
—
|
—
|
| Gain Loss On Sale Of PPE |
|
0.00
-100.00%
|
0.00
+0.00%
|
0.00
+200.00%
|
0.00
|
| Change In Working Capital |
|
25.12
-20.95%
|
31.78
+2016.89%
|
-1.66
-182.73%
|
2.00
|
| Change In Receivables |
|
-5.00
|
0.00
|
—
|
—
|
| Change In Prepaid Assets |
|
3.08
+413.46%
|
-0.98
-242.59%
|
0.69
+100.00%
|
0.34
|
| Change In Payables And Accrued Expense |
|
-0.83
-4764.71%
|
-0.02
+99.10%
|
-1.89
-191.21%
|
2.07
|
| Change In Accrued Expense |
|
-0.98
+36.55%
|
-1.54
-981.71%
|
0.17
-88.96%
|
1.58
|
| Change In Payable |
|
0.15
-90.04%
|
1.53
+173.97%
|
-2.06
-525.36%
|
0.48
|
| Change In Account Payable |
|
0.15
-90.04%
|
1.53
+173.97%
|
-2.06
-525.36%
|
0.48
|
| Change In Other Working Capital |
|
27.88
-14.96%
|
32.78
|
—
|
—
|
| Change In Other Current Assets |
|
—
|
0.54
+17.17%
|
0.46
+17.65%
|
0.39
|
| Change In Other Current Liabilities |
|
—
|
-1.05
-14.05%
|
-0.92
-14.61%
|
-0.80
|
| Investing Cash Flow |
|
-0.52
-1338.89%
|
-0.04
+92.59%
|
-0.49
+73.97%
|
-1.87
|
| Cash Flow From Continuing Investing Activities |
|
-0.52
-1338.89%
|
-0.04
+92.59%
|
-0.49
+73.97%
|
-1.87
|
| Net PPE Purchase And Sale |
|
-0.52
-1338.89%
|
-0.04
+92.59%
|
-0.49
+73.97%
|
-1.87
|
| Purchase Of PPE |
|
-0.52
-1338.89%
|
-0.04
+92.59%
|
-0.49
+73.97%
|
-1.87
|
| Capital Expenditure |
|
-0.52
-1338.89%
|
-0.04
+92.59%
|
-0.49
+73.97%
|
-1.87
|
| Financing Cash Flow |
|
87.78
+200.64%
|
29.20
+545.74%
|
-6.55
-9392.75%
|
-0.07
|
| Cash Flow From Continuing Financing Activities |
|
87.78
+200.64%
|
29.20
+545.74%
|
-6.55
-9392.75%
|
-0.07
|
| Net Issuance Payments Of Debt |
|
0.00
+100.00%
|
-3.38
+49.91%
|
-6.75
-7843.53%
|
-0.09
|
| Issuance Of Debt |
|
—
|
—
|
—
|
0.00
|
| Repayment Of Debt |
|
0.00
+100.00%
|
-3.38
+49.91%
|
-6.75
-7843.53%
|
-0.09
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
0.00
|
| Long Term Debt Payments |
|
0.00
+100.00%
|
-3.38
+49.91%
|
-6.75
-7843.53%
|
-0.09
|
| Net Long Term Debt Issuance |
|
0.00
+100.00%
|
-3.38
+49.91%
|
-6.75
-7843.53%
|
-0.09
|
| Net Common Stock Issuance |
|
40.66
+495.68%
|
6.83
|
0.00
|
0.00
|
| Proceeds From Stock Option Exercised |
|
47.12
+82.97%
|
25.75
+12649.01%
|
0.20
+1162.50%
|
0.02
|
| Net Other Financing Charges |
|
—
|
—
|
—
|
—
|
| Changes In Cash |
|
82.27
+662.98%
|
10.78
+114.25%
|
-75.66
+2.58%
|
-77.66
|
| Beginning Cash Position |
|
57.07
+23.29%
|
46.29
-62.04%
|
121.95
-38.91%
|
199.61
|
| End Cash Position |
|
139.34
+144.14%
|
57.07
+23.29%
|
46.29
-62.04%
|
121.95
|
| Free Cash Flow |
|
-5.51
+70.08%
|
-18.41
+73.35%
|
-69.11
+10.93%
|
-77.59
|
| Interest Paid Supplemental Data |
|
0.00
-100.00%
|
0.06
-89.18%
|
0.57
+3.24%
|
0.56
|
| Common Stock Issuance |
|
40.66
+495.68%
|
6.83
|
0.00
|
0.00
|
| Issuance Of Capital Stock |
|
40.66
+495.68%
|
6.83
|
0.00
|
0.00
|
| Net Preferred Stock Issuance |
|
—
|
—
|
—
|
0.00
|
| Preferred Stock Issuance |
|
—
|
—
|
—
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-16 View
- 8-K2026-04-16 View
- 42026-03-30 View
- 10-K2026-03-23 View
- 8-K2026-03-23 View
- 8-K2026-03-12 View
- 8-K2026-03-09 View
- 8-K2026-02-24 View
- 42026-02-17 View
- 8-K2026-02-12 View
- 8-K2026-01-08 View
- 42026-01-05 View
- 42026-01-05 View
- 42026-01-05 View
- 42026-01-05 View
- 8-K2026-01-05 View
- 42025-12-01 View
- 42025-11-25 View
- 42025-11-25 View
- 42025-11-25 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|